German innovation funding (NUB) and the new benefit assessment

In this webinar we will provide an introduction to the NUB funding and overview of how the new benefit assessment will provide impact on the innovation funding process.

The new benefit assessment by G-BA and IQWiG will create a significant change in the ability for early commercialization in Germany at the same time as it will provide an opportunity to perform a government funded clinical study. 

Agenda:

• Introduction to NUB - Dr Martin Braun
• Process and evidence requirements for the new benefit assessment - Mattias Kyhlstedt
• Understanding the evidence requirements and alternative ways to develop comparative data - Dr Oleg Borisenko
• Practical issues regarding the NUB process to consider - Mattias Kyhlstedt
• Q&A, all

The webinar is only open for industry.

Learn more about Dr Braun here: http://www.drmartinbraun.com/

Once you have registered below, you will receive an e-mail confirmation.